Phil Albinus is a former executive editor of Employee Benefit Adviser and Employee Benefit News.
For reprint and licensing requests for this article, click here.
More From Employee Benefit News
Small businesses face a growing HR gap — and rising compliance risks
For smaller organizations without dedicated human resources staff, routine tasks can mask bigger risks tied to employee disputes, benefits administration, and compliance requirements.
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
Benefits Think How AI can help care management programs to scale
Organizers should ask, "Where are patients getting stuck, where are teams overloaded, and where is the current process failing to scale?"
Women on GLP-1s and hormone therapy seek better clinical support
Metabolism-management drugs and hormone therapy are growing in popularity, but women need expert clinical oversight in conjunction with medication access.
Benefits Think Preparing benefits for the next wave: Gene therapy medications
As the scope of gene therapy grows, understanding their impact and cost can help organizations decide how to cover them through their healthcare plans.